BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23086671)

  • 1. Reviving neuroprotection using a new approach: targeting postsynaptic density-95 to arrest glutamate excitotoxicity.
    Savitz SI; Schäbitz WR
    Stroke; 2012 Dec; 43(12):3411-2. PubMed ID: 23086671
    [No Abstract]   [Full Text] [Related]  

  • 2. Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period.
    Juan WS; Huang SY; Chang CC; Hung YC; Lin YW; Chen TY; Lee AH; Lee AC; Wu TS; Lee EJ
    J Pineal Res; 2014 Mar; 56(2):213-23. PubMed ID: 24350898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targets of cytoprotection in acute ischemic stroke: present and future.
    Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
    Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of neuroprotection: Blood glutamate grabber.
    Castillo J; Loza MI; Mirelman D; Brea J; Blanco M; Sobrino T; Campos F
    J Cereb Blood Flow Metab; 2016 Feb; 36(2):292-301. PubMed ID: 26661174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limiting stroke-induced damage by targeting an acid channel.
    Benveniste M; Dingledine R
    N Engl J Med; 2005 Jan; 352(1):85-6. PubMed ID: 15635119
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischemic stroke: "acidotoxicity" is a perpetrator.
    Huang Y; McNamara JO
    Cell; 2004 Sep; 118(6):665-6. PubMed ID: 15369664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.
    Xiong ZG; Zhu XM; Chu XP; Minami M; Hey J; Wei WL; MacDonald JF; Wemmie JA; Price MP; Welsh MJ; Simon RP
    Cell; 2004 Sep; 118(6):687-98. PubMed ID: 15369669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in cerebral ischemia: a new approach for neuroprotection.
    Millán M; Arenillas J
    Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
    Timsit S; Menn B
    Clin Pharmacol Ther; 2012 Feb; 91(2):327-32. PubMed ID: 22218073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling adenosine's effects on stroke.
    Fricker J
    Mol Med Today; 2000 Feb; 6(2):48. PubMed ID: 10652476
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
    Abulrob A; Tauskela JS; Mealing G; Brunette E; Faid K; Stanimirovic D
    J Neurochem; 2005 Mar; 92(6):1477-86. PubMed ID: 15748165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain.
    Wang H; Zhang YL; Tang XC; Feng HS; Hu G
    Mol Pharmacol; 2004 Nov; 66(5):1160-8. PubMed ID: 15304552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia.
    Calabresi P; Cupini LM; Centonze D; Pisani F; Bernardi G
    Ann Neurol; 2003 Jun; 53(6):693-702. PubMed ID: 12783414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium.
    Zipfel GJ; Babcock DJ; Lee JM; Choi DW
    J Neurotrauma; 2000 Oct; 17(10):857-69. PubMed ID: 11063053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
    Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
    Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.
    Meloni BP; Brookes LM; Clark VW; Cross JL; Edwards AB; Anderton RS; Hopkins RM; Hoffmann K; Knuckey NW
    J Cereb Blood Flow Metab; 2015 Jun; 35(6):993-1004. PubMed ID: 25669902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
    Campos F; Sobrino T; Ramos-Cabrer P; Castillo J
    Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
    Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
    Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.
    Lebeurrier N; Liot G; Lopez-Atalaya JP; Orset C; Fernandez-Monreal M; Sonderegger P; Ali C; Vivien D
    Mol Cell Neurosci; 2005 Dec; 30(4):552-8. PubMed ID: 16209928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to neuroprotection trials in acute ischemic stroke.
    Tymianski M
    Stroke; 2013 Oct; 44(10):2942-50. PubMed ID: 24021680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.